Literature DB >> 29704306

Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness.

David Owen1, Ana Töpf1, Veeramani Preethish-Kumar2, Paulo José Lorenzoni3, Bas Vroling4, Rosana Herminia Scola3, Elza Dias-Tosta5, Argemiro Geraldo6, Kiran Polavarapu2, Saraswati Nashi2, Daniel Cox1, Teresinha Evangelista1, John Dawson1, Rachel Thompson1, Jan Senderek7, Steven Laurie8,9, Sergi Beltran8,9, Marta Gut8,9, Ivo Gut8,9, Atchayaram Nalini2, Hanns Lochmüller1,8,10.   

Abstract

Congenital myasthenic syndrome (CMS) is a heterogeneous disorder that causes fatigable muscle weakness. CMS has been associated with variants in the MuSK gene and, to date, 16 patients have been reported. MuSK-CMS patients present a different phenotypic pattern of limb girdle weakness. Here, we describe four additional patients and discuss the phenotypic and clinical relationship with those previously reported. Two novel damaging missense variants are described: c.1742T > A; p.I581N found in homozygosis, and c.1634T > C; p.L545P found in compound heterozygosis with p.R166*. The reported patients had predominant limb girdle weakness with symptom onset at 12, 17, 18, and 30 years of age, and the majority exhibited a good clinical response to Salbutamol therapy, but not to esterase inhibitors. Meta-analysis including previously reported variants revealed an increased likelihood of a severe, respiratory phenotype with null alleles. Missense variants exclusively affecting the kinase domain, but not the catalytic site, are associated with late onset. These data refine the phenotype associated with MuSK-related CMS.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  congenital myasthenic syndrome; late onset; limb girdle; muscle-specific kinase

Mesh:

Substances:

Year:  2018        PMID: 29704306     DOI: 10.1002/ajmg.a.38707

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  Isolated vocal cord paralysis in two siblings with compound heterozygous variants in MUSK: Expanding the phenotypic spectrum.

Authors:  Chaya Murali; Dong Li; Katheryn Grand; Hakon Hakonarson; Elizabeth Bhoj
Journal:  Am J Med Genet A       Date:  2019-02-04       Impact factor: 2.802

2.  Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome.

Authors:  Rachel Thompson; Gisèle Bonne; Paolo Missier; Hanns Lochmüller
Journal:  Emerg Top Life Sci       Date:  2019-01-28

Review 3.  The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies.

Authors:  An E Vanhaesebrouck; David Beeson
Journal:  Curr Opin Neurol       Date:  2019-10       Impact factor: 5.710

4.  Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure.

Authors:  Pedro M Rodríguez Cruz; Judith Cossins; Jonathan Cheung; Susan Maxwell; Sandeep Jayawant; Ruth Herbst; Dominic Waithe; Alexandr P Kornev; Jacqueline Palace; David Beeson
Journal:  Hum Mutat       Date:  2019-11-25       Impact factor: 4.878

5.  Congenital Vocal Cord Paralysis and Late-Onset Limb-Girdle Weakness in MuSK-Congenital Myasthenic Syndrome.

Authors:  Marcus V Pinto; Jacqui-Lyn Saw; Margherita Milone
Journal:  Front Neurol       Date:  2019-12-20       Impact factor: 4.003

Review 6.  Secreted Signaling Molecules at the Neuromuscular Junction in Physiology and Pathology.

Authors:  Bisei Ohkawara; Mikako Ito; Kinji Ohno
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

7.  The RD-Connect Genome-Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases.

Authors:  Steven Laurie; Davide Piscia; Leslie Matalonga; Alberto Corvó; Marcos Fernández-Callejo; Carles Garcia-Linares; Carles Hernandez-Ferrer; Cristina Luengo; Inés Martínez; Anastasios Papakonstantinou; Daniel Picó-Amador; Joan Protasio; Rachel Thompson; Raul Tonda; Mònica Bayés; Gemma Bullich; Jordi Camps-Puchadas; Ida Paramonov; Jean-Rémi Trotta; Angel Alonso; Marcella Attimonelli; Christophe Béroud; Virginie Bros-Facer; Orion J Buske; Andrés Cañada-Pallarés; José M Fernández; Mats G Hansson; Rita Horvath; Julius O B Jacobsen; Rajaram Kaliyaperumal; Séverine Lair-Préterre; Luana Licata; Pedro Lopes; Estrella López-Martín; Deborah Mascalzoni; Lucia Monaco; Luis A Pérez-Jurado; Manuel Posada de la Paz; Jordi Rambla; Ana Rath; Olaf Riess; Peter N Robinson; David Salgado; Damian Smedley; Dylan Spalding; Peter A C 't Hoen; Ana Töpf; Irina Zaharieva; Holm Graessner; Ivo G Gut; Hanns Lochmüller; Sergi Beltran
Journal:  Hum Mutat       Date:  2022-06       Impact factor: 4.700

Review 8.  Multiple MuSK signaling pathways and the aging neuromuscular junction.

Authors:  Lauren A Fish; Justin R Fallon
Journal:  Neurosci Lett       Date:  2020-04-28       Impact factor: 3.046

Review 9.  The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.

Authors:  Pedro M Rodríguez Cruz; Jacqueline Palace; David Beeson
Journal:  Int J Mol Sci       Date:  2018-06-05       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.